Early Detection and Prevention of Psychotic Disorders: Ready for “Prime Time”?
Tuesday, February 12, 2019, 2:00 pm EST
Research suggesting significantly better outcomes in schizophrenia when it is treated early has led to efforts to provide coordinated, multispecialty care as soon as possible to individuals who experience a first episode of psychosis. The next advance with a potentially game-changing impact will be the development of reliable means of identifying and treating those at high risk prior to a first psychotic episode. I will discuss efforts to develop more precise diagnostic measures using biomarkers and innovative treatments for preventive intervention, research that could lead disease-modifying treatments.
Watch webinar recording:
Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.
Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein served as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association from 2012 - 2023.
Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.
